178 related articles for article (PubMed ID: 26149729)
1. Re: Drug Adherence and Clinical Outcomes for Patients Under Pharmacological Therapy for Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia: Population-based Cohort Study.
Gravas S
Eur Urol; 2015 Aug; 68(2):338-9. PubMed ID: 26149729
[No Abstract] [Full Text] [Related]
2. Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study.
Cindolo L; Pirozzi L; Fanizza C; Romero M; Tubaro A; Autorino R; De Nunzio C; Schips L
Eur Urol; 2015 Sep; 68(3):418-25. PubMed ID: 25465970
[TBL] [Abstract][Full Text] [Related]
3. Adherence to therapy for lower urinary tract symptoms: don't mistake association with causation!
Penson DF
Eur Urol; 2015 Sep; 68(3):426-7. PubMed ID: 25703576
[No Abstract] [Full Text] [Related]
4. Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms.
Sarma AV; Wei JT
N Engl J Med; 2012 Jul; 367(3):248-57. PubMed ID: 22808960
[No Abstract] [Full Text] [Related]
5. Drug adherence and drug-related problems in pharmacotherapy for lower urinary tract symptoms related to benign prostatic hyperplasia.
Zabkowski T; Saracyn M
J Physiol Pharmacol; 2018 Aug; 69(4):. PubMed ID: 30552307
[TBL] [Abstract][Full Text] [Related]
6. Treatment of benign prostatic hyperplasia.
Nunes RV; Manzano J; Truzzi JC; Nardi A; Silvinato A; Bernardo WM;
Rev Assoc Med Bras (1992); 2017 Feb; 63(2):95-99. PubMed ID: 28355368
[No Abstract] [Full Text] [Related]
7. Re: Twelve-Month Medication Persistence in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia.
Kaplan SA
J Urol; 2015 Oct; 194(4):1056. PubMed ID: 26382807
[No Abstract] [Full Text] [Related]
8. Benign Prostatic Hyperplasia.
Langan RC
Prim Care; 2019 Jun; 46(2):223-232. PubMed ID: 31030823
[TBL] [Abstract][Full Text] [Related]
9. Medical treatment for benign prostatic hyperplasia: Where do we stand?
Rossanese M; Crestani A; Inferrera A; Giannarini G; Bartoletti R; Tubaro A; Ficarra V
Urologia; 2019 Aug; 86(3):115-121. PubMed ID: 31282310
[TBL] [Abstract][Full Text] [Related]
10. Finasteride or dutasteride for the pharmacological treatment for male lower urinary tract symptoms due to benign prostatic hyperplasia?
Alcántara-Montero A; Brenes-Bermúdez FJ
Actas Urol Esp; 2016 May; 40(4):268-9. PubMed ID: 26774534
[No Abstract] [Full Text] [Related]
11. Early symptom improvement and discontinuation of 5-α-reductase inhibitor (5ARI) therapy in patients with benign prostatic hyperplasia (BPH).
Kruep EJ; Phillips E; Hogue S; Eaddy M
Ann Pharmacother; 2014 Mar; 48(3):343-8. PubMed ID: 24311727
[TBL] [Abstract][Full Text] [Related]
12. Increased population use of medications for male lower urinary tract symptoms/benign prostatic hyperplasia correlates with changes in indications for transurethral resection of the prostate.
Ingimarsson JP; Isaksson HJ; Sigbjarnarson HP; Gudmundsson J; Geirsson G
Scand J Urol; 2014 Feb; 48(1):73-8. PubMed ID: 23924152
[TBL] [Abstract][Full Text] [Related]
13. A European Registry Evaluating Symptomatic Effectiveness of Pharmacologically Treated Patients with Lower Urinary Tract Symptoms due to Benign Prostatic Enlargement: Lessons Learned.
Tubaro A; Speakman M; de la Taille A; Martínez-Piñeiro L; Berges R; Patel A; Bjartell A; Caris C; Witjes W
J Urol; 2021 Apr; 205(4):1145-1152. PubMed ID: 33259270
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of dutasteride discontinuation in patients with benign prostatic hypertrophy.
Masuda H; Mikami K; Otsuka K; Hou K; Suyama T; Araki K; Kojima S; Naya Y
Arch Ital Urol Androl; 2022 Dec; 94(4):521-524. PubMed ID: 36576460
[TBL] [Abstract][Full Text] [Related]
15. Medical treatment of lower urinary tract symptoms/benign prostatic hyperplasia: anything new in 2015.
Schauer I; Madersbacher S
Curr Opin Urol; 2015 Jan; 25(1):6-11. PubMed ID: 25393269
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy for non-neurogenic male lower urinary tract symptoms: 1 + 1 does not equal 2.
Lepor H
Eur Urol; 2013 Aug; 64(2):244-6; discussion 246-7. PubMed ID: 23473577
[No Abstract] [Full Text] [Related]
17. Medical Treatment of Benign Prostatic Hyperplasia.
Plochocki A; King B
Urol Clin North Am; 2022 May; 49(2):231-238. PubMed ID: 35428429
[TBL] [Abstract][Full Text] [Related]
18. [Combination therapy for benign prostatic hyperplasia in the light of clinical guidelines].
Vinarov AZ; Spivak LG; Mironov AV
Urologiia; 2017 Sep; (4):120-128. PubMed ID: 28952704
[TBL] [Abstract][Full Text] [Related]
19. Re: Mauro Gacci, Giovanni Corona, Matteo Salvi, et al. A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol 2012;61:994-1003.
Yuan JQ; Yang ZY; Mao C
Eur Urol; 2012 Aug; 62(2):e35; author reply e36-8. PubMed ID: 22656724
[No Abstract] [Full Text] [Related]
20. Early Surgical Intervention is Beneficial in Avoiding Complications in Patients with Male Lower Urinary Tract Symptoms.
Bachmann A; Rapoport LM; Wetterauer C
Eur Urol Focus; 2018 Jan; 4(1):2-3. PubMed ID: 29680700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
